• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

November 20, 2019

Trending News Today: Women Face Disparities in Cardiovascular Outcomes Compared with Men

Top news of the day from across the health care landscape.

Lack of awareness among women regarding the perceived risk of cardiovascular disease and type 2 diabetes may contribute to disparities in outcomes between men and women, MD Magazine reported. According to the article, results from a meta-analysis of 5 million individuals presented at the American Heart Association 2019 Scientific Sessions found that diabetes is a stronger risk for coronary disease, cardiovascular disease, and all-cause mortality in women than it is in men. The authors noted that women also face discrepancy in both medication adherence and benefits from taking medication, as well as underrepresentation in clinical trials, the article reported.

On Tuesday, the American Medical Association (AMA) called for an immediate ban on all electronic cigarettes and vaping devices, The Associated Press reported. According to the article, the group aims to lobby for state and federal laws, regulations, or legal action to achieve a ban of vaping products. The AMA policy calls for the ban to include all vaping products not approved to help people quit smoking, even though none of these products have been reviewed or approved for smoking cessation by the FDA, the article reported.

The combination therapy nivolumab (Opdivo) and ipilimumab (Yervoy) missed the main goal of a late-stage trial for skin cancer, Reuters reported. According to the article, the study evaluated nivolumab and ipilimumab compared with nivolumab alone in patients with advanced melanoma. Overall, the combination failed to show a statistically significant benefit in patients whose tumors had a 1% or lower level of the PD-L1 protein being targeted, the article reported.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Gang | stock.adobe.com
Related Content
Advertisement
Close up,asian female doctor with syringe doing injection vaccine,flu,influenza in the shoulder of senior woman, nurse injecting,vaccinating elderly patient,vaccination,medicine,health care concept
August 24th 2025

Patients Express Confidence in Pneumococcal Vaccines Given by Pharmacists in Oncology Units

Luke Halpern, Assistant Editor
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 24th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
bipolar mental disorder. Double face. Split personality. Conceptual mood disorder. Dual personality concept. 2 silhouettes of a female head. mental health. Imaginatio - Image credit: Julia | stock.adobe.com
August 24th 2025

Study Reveals Subtle Heart Muscle Dysfunction in Bipolar Disorder Patients

Kennedy Ferruggia, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 24th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Abrysvo RSV vaccine, Respiratory Syncytial Virus vaccination for pregnant women, Australian immunisation program 2025, Queensland General PracticeImage credit: Cynthia | stock.adobe.com
August 24th 2025

RSVpreF Vaccine Is Well-Tolerated in Adults, Demonstrating Favorable Safety Profile

Kennedy Ferruggia, Assistant Editor
Vibrant Green Mitragyna Speciosa Plantation Leaves | Image Credit: Yonus | stock.adobe.com
August 24th 2025

Natural Alkaloids From Mitragyna speciosa Show Potential as Novel HER2 Inhibitors in Breast Cancer

Danielle Valletti, Assistant Editor
Related Content
Advertisement
Close up,asian female doctor with syringe doing injection vaccine,flu,influenza in the shoulder of senior woman, nurse injecting,vaccinating elderly patient,vaccination,medicine,health care concept
August 24th 2025

Patients Express Confidence in Pneumococcal Vaccines Given by Pharmacists in Oncology Units

Luke Halpern, Assistant Editor
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 24th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
bipolar mental disorder. Double face. Split personality. Conceptual mood disorder. Dual personality concept. 2 silhouettes of a female head. mental health. Imaginatio - Image credit: Julia | stock.adobe.com
August 24th 2025

Study Reveals Subtle Heart Muscle Dysfunction in Bipolar Disorder Patients

Kennedy Ferruggia, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 24th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Abrysvo RSV vaccine, Respiratory Syncytial Virus vaccination for pregnant women, Australian immunisation program 2025, Queensland General PracticeImage credit: Cynthia | stock.adobe.com
August 24th 2025

RSVpreF Vaccine Is Well-Tolerated in Adults, Demonstrating Favorable Safety Profile

Kennedy Ferruggia, Assistant Editor
Vibrant Green Mitragyna Speciosa Plantation Leaves | Image Credit: Yonus | stock.adobe.com
August 24th 2025

Natural Alkaloids From Mitragyna speciosa Show Potential as Novel HER2 Inhibitors in Breast Cancer

Danielle Valletti, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.